4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-15-064734
CIK 0001373707operating
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 6:48 PM ET
Size
9.4 KB
Accession
0001209191-15-064734
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2015-08-05$14.45/sh+10,000$144,500→ 10,343 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-08-05−10,000→ 167,501 totalExercise: $14.45Exp: 2024-02-02→ Common Stock (10,000 underlying) - Sale
Common Stock
2015-08-05$46.31/sh−10,000$463,100→ 343 total
Footnotes (3)
- [F1]The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2015.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $44.92 to $47.60 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]This option vested as to 20% of the shares on February 3, 2014 and another 20% on February 3, 2015 and further vests as to 5% of the shares at the end of each successive three-month period thereafter until February 3, 2018.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 6:48 PM ET
- Size
- 9.4 KB